MetaCap

Xtant Medical Holdings Inc. (XTNT)

NYSE: XTNTHealth CareMedical/Dental InstrumentsUSD

0.21-0.0061 (-2.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XTNT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$29.49M
EPS (TTM)
-$0.11
52-week range
0.17 – 0.84
Day range
0.2016 – 0.2499
Volume / Avg
257.13K / 1.69M
Beta
—

52-week range

$0.17$0.84

XTNT stock today

Xtant Medical (XTNT) closed at $0.21 on Nov 20, down 2.82% (-$0.0061), versus the S&P 500's 3.70% decline. Trading was light, with 257.13K shares changing hands, about 15% of the average daily volume. At this level, XTNT sits near the bottom of its 52-week range of $0.17 to $0.84: 75.0% below the high, set on Dec 18, 2025 and 23.5% above the low.

XTNT is down 73.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 66.1%. Xtant Medical has posted a net loss over the last twelve months (EPS of -$0.11), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Xtant Medical

Company profile

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.

Industry
Medical/Dental Instruments
CEO
Mr. Sean E. Browne
Headquarters
Belgrade, MT
Employees
151

Financial highlights

Full financials

In fiscal 2025, Xtant Medical generated $133.9 million in revenue, up 14.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $5.0 million, for a net margin of 3.7% versus a median of -13.2% in the prior 5 years. Gross margin was 62.9% (up from 58.2%) and operating margin 5.4%.

Xtant Medical annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$133.93M$117.27M$91.30M$57.97M$55.26M
Growth+14.21%+28.44%+57.50%+4.90%+3.61%
Net income$4.97M$-16.45M$660.00K$-8.48M$-4.85M
EPS (diluted)$0.03$-0.12$0.01$-0.09$-0.06

Analyst forecast

Forecast

Consensus (3 analysts)

none

Avg. price target

$1.03+390.48%

  • Strong buy 1
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $0.60High $1.50

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$-0.03 vs —

XTNT news

All XTNT news

Xtant Medical peers

Health Care sector
XTNT peer companies
CompanyPrice% ChgMarket capCompare
NSPRInspireMD Inc.0.54-12.97%$29.23Mvs XTNT
NEPHNephros Inc.2.61-8.10%$28.37Mvs XTNT
TELATELA Bio Inc.0.6885-5.27%$31.11Mvs XTNT
MDAISpectral AI Inc. Class A1.04-20.61%$33.47Mvs XTNT
PLRZPolyrizon Ltd.9.31-8.42%$22.61Mvs XTNT
DAVIDavion Healthcare Plc0.9001-9.99%$22.50Mvs XTNT
SRTSSensus Healthcare Inc.2.26-4.24%$37.20Mvs XTNT
PMIPicard Medical Inc.6.79+7.78%$18.07Mvs XTNT

Indexes, lists and sector

Xtant Medical stock FAQ

What is Xtant Medical's stock price today?

XTNT last traded at $0.21 as of Nov 20, 4:00 PM EST, down 2.82% on the day. Prices are delayed at least 15 minutes.

Does Xtant Medical pay a dividend?

No. Xtant Medical does not currently pay a regular cash dividend.

Who is Xtant Medical's CEO?

Mr. Sean E. Browne is the chief executive officer of Xtant Medical Holdings Inc., which has about 151 employees.

Has XTNT ever split its stock?

Yes. The most recent XTNT stock split was a 1-for-12 split on Feb 14, 2018, one of 2 splits on record.

What is the XTNT 52-week high?

The 52-week high for XTNT is $0.84 and the 52-week low is $0.17. The stock is currently 75.0% below its high.

Compare XTNT